Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
Clinical trial NCT03442088 · COMPLETED
Trial details
- NCT number
- NCT03442088
- Sponsor
- University Hospitals Cleveland Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2021-09-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.